Indexed on: 09 Nov '16Published on: 02 Nov '16Published in: International Journal of Cardiology
First generation paclitaxel-eluting stents (PES) and second generation everolimus-eluting stents (EES) were approved for use in percutaneous coronary interventions (PCIs) in 2004 and 2008, respectively. However, relative long-term outcomes of PES vs EES in real practice remain unclear. We sought to determine the long-term comparative effectiveness of PES vs EES using New York State (NYS) cardiac registries and to assess long-term outcomes of PES vs ZES in six “off-label” and two “high-risk” patient subgroups.
Indexed on: 26 Sep '13
Published on: 26 Sep '13 in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Indexed on: 27 Jul '15
Published on: 27 Jul '15 in JACC: Cardiovascular Interventions